Orally administered NHE1 inhibitor cariporide reduces acute responses to coronary occlusion and reperfusion

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 276, Issue 2 45-2, 1999, Pages

  Humphreys, Rachael A ^a   Haist, James V ^a   Chakrabarti, Subrata ^a   Feng, Qingping ^a   Arnold, J Malcolm O ^a   Karmazyn, Morris ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Apoptosis; Arrhythmias; HOE 642; Infarction; Sodium hydrogen exchange; Sodium hydrogen exchanger subtype 1 messenger ribonucleic acid expression

Indexed keywords

CARIPORIDE; CARRIER PROTEIN; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; DIET; HEART ARRHYTHMIA; HEART INFARCTION; HEART PROTECTION; MALE; MORTALITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; RAT; REPERFUSION;

EID: 0033056611     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.276.2.h749     Document Type: Article

References (23)

1. Chakrabarti, S., A. N. E. Hoque, and M. Kannazyn. A rapid ischemia-induced apoptosis in isolated rat hearts and its attenuation by the sodium-hydrogen exchange inhibitor HOE 642 (cariporide). J. Mol. Cell. Cardiol. 29: 3169-3174, 1997.
2. Dyck, J. R. B., T. G. Maddaford, G. N. Pierce, and L. Fliegel. Induction of expression of the sodium-hydrogen exchanger in rat myocardium. Cardiovasc. Res. 29: 203-208, 1995.
3. + exchanger attenuates neutrophil-mediated reperfusion injury. Ann. Thorac. Surg. 60: 377-381, 1995.
4. + exchanger. Mol. Cell. Biochem. 125: 137-143, 1993.
5. Fliss, H., and D. Gattinger. Apoptosis in ischemic and reperfused rat myocardium. Circ. Res. 79: 949-956, 1996.
6. Fröhlich, O., and M. Karmazyn. The Na-H exchanger revisited: an update on Na-H exchange regulation and the role of the exchanger in hypertension and cardiac function in health and disease. Cardiovasc. Res. 36: 138-148, 1997.
7. Gumina, R. J., T. Mizumura, N. Beier, P. Schelling, J. J. Schultz, and G. J. Gross. A new sodium/hydrogen exchange inhibitor, EMD 85131, limits infarct size in dogs when administered before or after coronary occlusion. J. Pharmacol. Exp. Ther. 286: 175-183, 1997.
8. Hockenbery, D. M., M. Zutter, W. Hickey, M. Nahm, and S. J. Korsmeyer. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. USA 88: 6961-6965, 1991.
9. + exchange inhibition protects against mechanical, ultrastructural, and biochemical impairment induced by low concentrations of lysophosphatidylcholine in isolated rat hearts. Circ. Res. 80: 95-102, 1997.
10. Hoque, A. N. E., and M. Karmazyn. Effect of sodium-hydrogen exchange inhibition on functional and metabolic impairment produced by oxidative stress in the isolated rat heart. Can. J. Physiol. Pharmacol. 75: 326-334, 1997.
11. + Exchanger, edited by L. Fliegel. Austin, TX: Landes, 1996, p. 189-215.
12. Kleyman, T. R., and E. J. Cragoe. Amiloride and its analogs as tools in the study of ion transport. J. Membr. Biol. 105: 1-21, 1988.
13. Krajewski, S., M. Krajewski, A. Shabaik, T. Miyashita, H. G. Wang, and J. C. Reed. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am. J. Pathol. 145: 1323-1336, 1994.
14. Kroemer, G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 3: 614-620, 1997.
15. Lazdunski, M., C. Frelin, and P. Vigne. The sodium/hydrogen exchange system in cardiac cells: its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J. Mol. Cell. Cardiol. 17: 1029-1042, 1985.
16. Mathur, S., and M. Karmazyn. Interaction between anesthetics and the sodium-hydrogen exchange inhibitor HOE 642 (cariporide) in ischemic and reperfused rat hearts. Anesthesiology 87: 1460-1469, 1996.
17. McCarty, K. S., Jr., L. S. Miller, E. B. Cox, J. Konrath, and K. S. McCarthy, Sr. Estrogen receptor analysis. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch. Pathol. Lab. Med. 109: 716-721, 1985.
18. Pierce, G. N., and M. P. Czubryt. The contribution of ionic imbalance to ischemia/reperfusion-induced injury. J. Mol. Cell. Cardiol. 27: 53-63, 1995.
19. Scholz, W., U. Albus, L. Counillon, H. Gögelein, H.-J. Lang, W. Linz, A. Weichert, and B. A. Schölkens. Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion. Cardiovasc. Res. 29: 260-268, 1995.
20. + exchanger activity does not contribute to protection by ischemic preconditioning in the isolated rat heart. Circulation 96: 3617-3625, 1997.
21. Veinot, J. P., D. A. Gattinger, and H. Fliss. Early apoptosis in human myocardial infarcts. Hum. Pathol. 28: 485-492, 1997.
22. Walker, M. J. A., M. J. Curtis, D. J. Hearse, R. W. F. Campbell, M. J. Janse, D. M. Yellon, S. M. Cobbe, S. J. Coker, J. B. Harness, D. W. G. Harron, A. J. Higgins, D. G. Julian, M. J. Lab, A. S. Manning, B. J. Northover, J. Parratt, R. A. Riemersma, E. Riva, D. C. Russell, D. J. Sheridan, E. Winslow, and B. Woodward. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovasc. Res. 22: 447-455, 1988.
23. Yeh, E. T. H. Life and death in the cardiovascular system. Circulation 95: 782-786, 1997.